The news story you are looking for has expired. A more recent related article is displayed below.

Ads by Google

GlycoMimetics raises $38 million in venture round of funding

GlycoMimetics, Inc., a US-based clinical-stage biotechnology company, has raised $38 million in its latest round of venture financing.

New investor Genzyme Ventures joined the existing investors New Enterprise Associates, Inc. (NEA), Novartis Venture Funds, Anthem Capital Management, LLC and Alliance Technology Ventures in this round.

Deal Value (US$ Million) 38
Deal Type                Venture Finance
Sub-Category             Growth Capital/Expansion
Deal Status              Completed: 2009-10-20

Deal Participants

Target (Company) GlycoMimetics, Inc.

Deal Rationale

GlycoMimetics will use the investment to fund a phase 2 trial of its lead drug candidate GMI-1070 in vaso-occlusive crisis of sickle cell disease. The company also intends to use the proceeds to fund a phase 2 study of GMI-1070 in a second clinical indication.

Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved

News Provided by COMTEX


Related terms: biotechnology, clinical, disease, expansion, technology, trial

Related Articles

Venture capital firms sell Proteolix to Onyx Pharmaceuticals - Zibb.com
Nov 16, 2009
...Ventures, Westfield Capital Management, Advanced Technology Ventures, Delphi Ventures...Ventures, Westfield Capital Management, Advanced Technology Ventures, Delphi Ventures...Deal Type Venture Finance Sub-Category Exit...

Kona Grill Appoints Marc Buehler CEO
Nov 2, 2009
...managing member of BBS Capital Management, LP, a Texas limited... Prior to forming BBS Capital Management, LP, Mr. Bakay was...portfolio manager of Patara Capital Management, LP (an investment management...

Liongate Capital Management announces opening of office in the DI...
Nov 10, 2009
...explored as Abu Dhabi... Liongate Capital Management announces opening of office in the...Software for trading on DGCX Liongate Capital Management announces opening of office in the...ago PRESS RELEASE Liongate Capital Management, the award-winning fund of...

Liberty Global buys Unitymedia
Nov 13, 2009
...believed to own about 35% of Unitymedia while Apollo owns 31%, and smaller stakes are held by funds such as Och-Ziff Capital Management. Unitymedia managers hold about 6%. Unitymedia has 4.5 million subscribers, of which 470,000...